CNTG
Income statement / Annual
Last year (2023), Centogene N.V.'s total revenue was $47.54 M,
an increase of 0.14% from the previous year.
In 2023, Centogene N.V.'s net income was -$34.80 M.
See Centogene N.V.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
Operating Revenue |
$47.54 M
|
$47.47 M
|
$189.92 M
|
$128.38 M
|
$48.78 M
|
$40.48 M
|
$31.69 M
|
$27.67 M
|
Cost of Revenue |
$35.93 M |
$27.71 M |
$161.77 M |
$86.38 M |
$26.01 M |
$19.94 M |
$14.94 M |
$12.86 M |
Gross Profit |
$11.61 M |
$19.76 M |
$28.16 M |
$42.00 M |
$22.78 M |
$20.54 M |
$16.75 M |
$14.81 M |
Gross Profit Ratio |
0.24 |
0.42 |
0.15 |
0.33 |
0.47 |
0.51 |
0.53 |
0.54 |
Research and Development
Expenses |
$10.17 M
|
$17.49 M
|
$19.30 M
|
$14.94 M
|
$9.59 M
|
$6.30 M
|
$6.40 M
|
$5.89 M
|
General & Administrative
Expenses |
$29.17 M
|
$29.21 M
|
$44.79 M
|
$37.67 M
|
$23.16 M
|
$18.61 M
|
$9.50 M
|
$8.89 M
|
Selling & Marketing
Expenses |
$12.56 M
|
$9.92 M
|
$9.86 M
|
$7.58 M
|
$9.25 M
|
$7.47 M
|
$5.90 M
|
$5.36 M
|
Selling, General &
Administrative Expenses |
$41.68 M
|
$39.13 M
|
$54.65 M
|
$45.25 M
|
$32.41 M
|
$26.08 M
|
$15.40 M
|
$14.25 M
|
Other Expenses |
$1.91 M |
-$340,000.00 |
-$970,000.00 |
-$2.22 M |
$109,000.00 |
-$2.14 M |
$0.00 |
$290,514.00 |
Operating Expenses |
$49.93 M |
$56.28 M |
$72.98 M |
$57.96 M |
$42.11 M |
$30.25 M |
$21.28 M |
$19.21 M |
Cost And Expenses |
$85.86 M |
$83.99 M |
$234.74 M |
$144.34 M |
$68.12 M |
$50.19 M |
$36.22 M |
$32.07 M |
Interest Income |
$209,000.00 |
$3,000.00 |
$3,000.00 |
$6,000.00 |
$16,000.00 |
$33,000.00 |
$14,000.00 |
$26,000.00 |
Interest Expense |
$8.20 M |
$3.57 M |
$851,000.00 |
$1.04 M |
$2.03 M |
$1.08 M |
$1.02 M |
$829,000.00 |
Depreciation &
Amortization |
$7.45 M
|
$10.19 M
|
$20.77 M
|
$14.09 M
|
$6.56 M
|
$5.34 M
|
$3.04 M
|
$2.19 M
|
EBITDA |
-$30.87 M
|
-$26.00 M
|
-$23.53 M
|
-$823,000.00
|
-$12.74 M
|
-$4.50 M
|
-$1.28 M
|
-$2.29 M
|
EBITDA Ratio |
-0.65 |
-0.55 |
-0.12 |
-0.01 |
-0.26 |
-0.11 |
-0.04 |
-0.08 |
Operating Income Ratio
|
-0.81
|
-0.77
|
-0.24
|
-0.12
|
-0.4
|
-0.26
|
-0.14
|
-0.18
|
Total Other
Income/Expenses Net |
$4.09 M
|
-$2.08 M
|
-$2.06 M
|
-$5.14 M
|
-$1.36 M
|
-$895,000.00
|
$75,000.00
|
-$563,000.00
|
Income Before Tax |
-$34.23 M |
-$38.60 M |
-$46.88 M |
-$21.10 M |
-$20.70 M |
-$11.65 M |
-$5.46 M |
-$5.77 M |
Income Before Tax Ratio
|
-0.72
|
-0.81
|
-0.25
|
-0.16
|
-0.42
|
-0.29
|
-0.17
|
-0.21
|
Income Tax Expense |
$281,117.00 |
$107,000.00 |
-$24,000.00 |
$281,000.00 |
$158,000.00 |
-$310,000.00 |
$14,000.00 |
-$408,000.00 |
Net Income |
-$34.80 M |
-$38.70 M |
-$46.85 M |
-$21.38 M |
-$20.86 M |
-$11.34 M |
-$5.48 M |
-$5.36 M |
Net Income Ratio |
-0.73 |
-0.82 |
-0.25 |
-0.17 |
-0.43 |
-0.28 |
-0.17 |
-0.19 |
EPS |
-1.24 |
-1.44 |
-2.09 |
-1.02 |
-1.27 |
-0.57 |
-0.28 |
-0.27 |
EPS Diluted |
-1.24 |
-1.44 |
-2.09 |
-1.02 |
-1.27 |
-0.57 |
-0.28 |
-0.27 |
Weighted Average Shares
Out |
$28.16 M
|
$26.81 M
|
$22.44 M
|
$20.91 M
|
$16.41 M
|
$19.86 M
|
$19.86 M
|
$19.86 M
|
Weighted Average Shares
Out Diluted |
$28.16 M
|
$26.81 M
|
$22.44 M
|
$20.91 M
|
$16.41 M
|
$19.86 M
|
$19.86 M
|
$19.86 M
|
Link |
|
|
|
|
|
|
|
|